文献速递糖尿病

瞬感血糖监测技术对2型糖尿病患者血糖控制及治疗满意度的影响

Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2019-04-29

这项随机对照研究纳入101例接受每日多次胰岛素注射(MDI)至少1年的2型糖尿病患者,随机分为瞬感血糖监测(FGM)干预组(n=53)和标准治疗对照组(n=48),随访10周。结果显示FGM组治疗灵活性显著更高(P=0.019)且更愿意推荐给病友(P=0.023),HbA1c降幅为-0.82%(9 mmol/mol)对-0.33%(3.6 mmol/mol)(P=0.005),且未增加低血糖频率。

要点

  • FGM可显著改善MDI治疗的2型糖尿病患者的治疗满意度与灵活性。
  • FGM组HbA1c降幅大于对照组(-0.82% vs -0.33%,P=0.005)。
  • FGM未增加低血糖事件频率,安全性良好。

核心结论

  • FGM倾向于改善MDI治疗的2型糖尿病患者的治疗满意度,并可能改善血糖控制而不增加低血糖频率。

研究设计与样本

  • 随机对照研究,纳入101例接受MDI至少1年的2型糖尿病患者,随机分为FGM干预组(n=53)和标准治疗对照组(n=48),随访10周。

主要发现

  • 干预组认为治疗显著更灵活(P=0.019),且更愿意推荐给病友(P=0.023)。
  • FGM系统使用满意度高。
  • HbA1c变化:干预组-0.82%(9 mmol/mol),对照组-0.33%(3.6 mmol/mol),P=0.005。
  • 非预设事后分析中,干预组68.6%的患者HbA1c降低≥0.5%(5.5 mmol/mol),对照组为30.2%(P<0.001)。
  • 干预组39.2%的患者HbA1c降低≥1.0%(10.9 mmol/mol),对照组为18.6%(P=0.0023),且未增加低血糖频率。

临床怎么用

  • 对于接受MDI治疗的2型糖尿病患者,可考虑使用FGM以提升治疗满意度和血糖控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess treatment satisfaction and the effectiveness of a flash glucose monitoring (FGM) system in patients with type 2 diabetes using insulin. RESEARCH DESIGN AND METHODS: A total of 101 patients with type 2 diabetes on multiple daily insulin injections (MDI) for at least 1 year were assigned randomly to the FGM intervention (n = 53) or the standard care (control) group (n = 48) and followed for 10 weeks. Both groups were instructed to adjust their insulin doses in face-to-face and telephone visits. Satisfaction with treatment, quality of life, comfort using FGM, HbA1c, and frequency of hypoglycemic events were evaluated. RESULTS: The intervention group found treatment significantly more flexible (P = 0.019) and would recommend it to their counterparts (P = 0.023). Satisfaction using the FGM system was high. The changes in HbA1c were -0.82% (9 mmol/mol) vs. -0.33% (3.6 mmol/mol) in the intervention and control group, respectively (P = 0.005); in nonprespecified post hoc analysis, 68.6% of the patients in the intervention group had their HbA1c reduced by ≥0.5% (5.5 mmol/mol) compared with 30.2% in the control group (P < 0.001), and 39.2% had their HbA1c reduced by ≥1.0% (10.9 mmol/mol) vs. 18.6% in the control group (P = 0.0023) without an increased frequency of hypoglycemia. CONCLUSIONS: FGM tends to improve treatment satisfaction and may lead to amelioration of glycemic control in patients with type 2 diabetes on MDI without increasing the frequency of hypoglycemia.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of Flash Glucose Monitoring Technology on Glycemic Control and Treatment Satisfaction in Patients With Type 2 Diabetes. Diabetes Care. 2019. PMID: 31036546. doi:10.2337/dc18-0166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。